Financial/Revenue Cycle Management
Dr. Michael Poku, chief clinical officer at Equality Health, talks tech needed to successfully tackle inequity, the benefits of investment in independent primary care physicians and how providers can work on the costs of health inequities.
The cochairs of FAST Deepak Sadagopan and Duncan Weatherston say FHIR standards provide a consistent pathway to address the variability and costs of payer and provider data exchange and achieve interoperability goals.
Rev1 Ventures, which announced Catalyst Fund III to invest in innovative life sciences companies, is a beneficial partner for startups and founders in the Great Lakes region, according to Ryan Helon, EVP.
According to Health Cluster Portugal Executive Director Joaquim Cunha, his association amplifies Portugal's healthcare competitiveness and innovation by coordinating multiple stakeholders.
HIMSS23 Europe's Startup PitchFest judge Anca del Rio explains what makes a successful health tech startup, including starting with good intentions and adding capital and commerciality.
AICEP's chairman, Filipe Santos Costa, explains how Portugal attracts tech startups while also optimising infrastructure, licensing and financial incentives to bring in pharma companies.
The commitment to telehealth from CMS offers medical specialties the freedom to innovate and provide better and more equitable care, says Dr. Robert Murry, chief medical officer of NextGen Healthcare and a practicing family physician.
According to the French Ministry of Health's Louisa Stuwe, digital devices for remote patient monitoring and digital therapeutics now enjoy fast-track access and reimbursement in France. The process is comparable to Germany's DiGA.
According to the French Ministry of Health's Louisa Stuwe, the national "Ma Santé 2022" strategy engaged multiple stakeholder and citizen consultations and secured essential funding to pave the way for a national digital health doctrine.
There are 13 startups from PharmaStars' cohort on digital innovation for women's health and health equity, and the accelerators' next cohort, Digital Innovations in Therapeutic Delivery. Naomi Fried, CEO and founder of PharmStars, offers a deep dive.
